Search
for
Sort by
Research 211–240 of 1000+
- [Dermatologic therapy unit anti-androgens].
- Pharmacological basis for clinical use of antiandrogens
- The antiandrogens. When and how they should be used.
- Do Pleiotropic Effects of Spironolactone in Women with PCOS make it More Than an Anti-Androgen? Evidence from a Systematic Review and Meta-Analysis
- The Development and Evaluation of An Ovulation Inhibitor (Diane®) Containing An Antiandrogen
- The involvement of androgens in human hair growth
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Guava (Psidium guajava L.) Leaf Extract as Bioactive Substances for Anti-Androgen and Antioxidant Activities
- Anti-androgenic and Hair Growth Promoting Activities of Lygodii Spora (Spore of Lygodium japonicum) I. Active Constituents Inhibiting Testosterone 5.ALPHA.-Reductase.
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Botanical drug preparations for alleviating hair loss in menopausal women: a global ethnopharmacological mini-review
- Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?
- Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials
- [Antiandrogen therapy of acne, falling hair and hirsutism (author's transl)].
- A systematic review of antiandrogens and feminization in transgender women
- Is There a Role for Antiandrogen Therapy for Hidradenitis Suppurativa? A Systematic Review of Published Data
- Hair aging and anti-aging
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Silencing the androgen receptor: New skills for antiandrogen oligonucleotide skin and hair therapy
- Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies
- 5α-Reductase Inhibitory Components as Antiandrogens From Herbal Medicine
- Cutaneous hyperandrogenism: role of antiandrogen therapy in acne, hirsutism, and androgenetic alopecia.
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
- Hormone Blocking Anticancer Drugs
- Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamide (The EAT-Proxa Biochemical AndroCoV-Trial)
- Improving the efficacy of anti-hair loss drugs treatments with a cosmetic lotion containing caffeine, taurine and growth factors